Detalhe da pesquisa
1.
An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
Cancer Sci;
115(4): 1102-1113, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38287511
2.
Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth.
J Transl Med;
22(1): 532, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38831284
3.
Intratumoral administration of unconjugated Accum™ impairs the growth of pre-established solid lymphoma tumors.
Cancer Sci;
114(12): 4499-4510, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37776054
4.
Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy.
Molecules;
27(12)2022 Jun 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35744930
5.
A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses.
iScience;
27(3): 109248, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38433914
6.
Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.
Cell Rep Med;
3(3): 100534, 2022 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35492876